1. The invasive T1 bladder tumor: Contemporary issues and rationale for radical cystectomy

   • John P. Stein
   • David F. Penson

   Invited Commentary 18 May 2008 Pages: 179 - 181

2. Possible malignancy after cytology analysis in a 45-year-old man

   • Mark Soloway

   OriginalPaper 18 May 2008 Pages: 182 - 184

3. Web alert

   OriginalPaper 18 May 2008 Pages: 185 - 185

4. Rationale for statins in the chemoprevention of prostate cancer

   • Robert J. Hamilton
   • Stephen J. Freedland

   OriginalPaper 18 May 2008 Pages: 189 - 196

5. Androgen deprivation therapy and risk for diabetes and cardiovascular disease in prostate cancer survivors

   • Matthew R. Smith

   OriginalPaper 18 May 2008 Pages: 197 - 202

6. Role of radical prostatectomy in the treatment of high-risk prostate cancer

   • Ofer Yossepowitch
   • James A. Eastham

   OriginalPaper 18 May 2008 Pages: 203 - 210

7. Watchful waiting versus active surveillance: Appropriate patient selection

   • Marc A. Dall’Era
   • Christopher J. Kane

   OriginalPaper 18 May 2008 Pages: 211 - 216

8. Dietary interventions in prostate cancer

   • Wendy Demark-Wahnefried

   OriginalPaper 18 May 2008 Pages: 217 - 225

9. The use of prostate-specific antigen kinetics to stratify risk in prostate cancer

   • Joseph Presti Jr

   OriginalPaper 18 May 2008 Pages: 226 - 230

10. Radical prostatectomy: Surgical planning, execution, and outcomes

    • Fernando J. Bianco Jr

    OriginalPaper 18 May 2008 Pages: 231 - 236

11. Extended lymph node dissection for prostate cancer

    • Stephan Jeschke
    • Fiona C. Burkhard
    • Urs E. Studer

    OriginalPaper 18 May 2008 Pages: 237 - 242

12. Inflammation and prostate cancer: A focus on infections

    • Siobhan Sutcliffe
    • Elizabeth A. Platz

    OriginalPaper 18 May 2008 Pages: 243 - 249

13. Advances in robotic prostatectomy

    • Stephen A. Boorjian
    • Matthew T. Gettman

    OriginalPaper 18 May 2008 Pages: 250 - 256